Partners & network
Introduce a community to physician-led longevity care, or discuss how HLC’s clinical operating model could support an existing or future care organization.
HLC can provide an agreed introduction, a clear HLP or private-consultation route and concierge orientation for participating people. The partner introduces the opportunity through agreed communications; HLC handles individual contact, clinical eligibility and care coordination. This format can work without the partner operating an onsite clinic.
HLC can explain the available service options, coordinate practical access for an individual, couple or family and work with an authorized assistant on timing and logistics. Every person keeps a separate clinical relationship, consent, record and medical decision. The organization never receives medical information merely because it made the introduction.
Use the link or code provided by your participating organization. The invitation is checked before any partner-specific terms are shown. If the invitation cannot be validated, you can explore the standard HLP route or ask Concierge for help.
An introduction does not give the organization access to your medical records. Any information sharing requires an appropriate basis and clear explanation. A partner cannot determine the clinician’s recommendation.
Our relationship with Longevitytech.fund connects a global network of scientists and biotechnology companies with HLC’s clinical teams, diagnostics and ongoing care. It gives us a practical role in learning how promising science translates into people’s lives.
Longevitytech.fund’s portfolio and wider scientific network bring sustained contact with founders, researchers and emerging platforms. HLC can discuss the underlying mechanisms, the available evidence and the questions still to be answered directly with the teams developing them. This informs the selection of research opportunities and our understanding of the field.
HLC contributes clinical facilities, medical expertise, participant coordination and longitudinal follow-up to selected research work, including carefully designed first-in-human evaluation. A defined question is paired with the applicable research pathway, appropriate participants, responsible professionals and a measurement plan. This is how scientific access can become useful human evidence.
Clinical laboratory results, biological-age platforms, organ-system analysis and functional tests can examine different aspects of a response. Looking across these measures helps the team assess positive findings alongside unchanged, unfavorable or uncertain results.
Findings feed back to researchers and clinical teams. They can refine monitoring, participant selection, follow-up and future protocol design. Prague provides an advanced clinical and translation base, while Miami supports private-client care and HLC’s U.S. innovation platform; Boca Raton contributes consultation and continuity care.
Begin with the Healthy Longevity Plan, or arrange a private conversation about broader assessment and ongoing care.
